Literature DB >> 27140636

Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6.

Anders Allgardsson1, Lotta Berg2, Christine Akfur1, Andreas Hörnberg3, Franz Worek4, Anna Linusson5, Fredrik J Ekström6.   

Abstract

Organophosphorus nerve agents interfere with cholinergic signaling by covalently binding to the active site of the enzyme acetylcholinesterase (AChE). This inhibition causes an accumulation of the neurotransmitter acetylcholine, potentially leading to overstimulation of the nervous system and death. Current treatments include the use of antidotes that promote the release of functional AChE by an unknown reactivation mechanism. We have used diffusion trap cryocrystallography and density functional theory (DFT) calculations to determine and analyze prereaction conformers of the nerve agent antidote HI-6 in complex with Mus musculus AChE covalently inhibited by the nerve agent sarin. These analyses reveal previously unknown conformations of the system and suggest that the cleavage of the covalent enzyme-sarin bond is preceded by a conformational change in the sarin adduct itself. Together with data from the reactivation kinetics, this alternate conformation suggests a key interaction between Glu202 and the O-isopropyl moiety of sarin. Moreover, solvent kinetic isotope effect experiments using deuterium oxide reveal that the reactivation mechanism features an isotope-sensitive step. These findings provide insights into the reactivation mechanism and provide a starting point for the development of improved antidotes. The work also illustrates how DFT calculations can guide the interpretation, analysis, and validation of crystallographic data for challenging reactive systems with complex conformational dynamics.

Entities:  

Keywords:  acetylcholinesterase; crystallography; density functional theory; nerve agent; reactivation

Mesh:

Substances:

Year:  2016        PMID: 27140636      PMCID: PMC4878515          DOI: 10.1073/pnas.1523362113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Quantum chemical geometry optimizations in proteins using crystallographic raw data.

Authors:  Ulf Ryde; Lars Olsen; Kristina Nilsson
Journal:  J Comput Chem       Date:  2002-08       Impact factor: 3.376

3.  A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase.

Authors:  I B WILSON; B GINSBURG
Journal:  Biochim Biophys Acta       Date:  1955-09

4.  The energy landscapes and motions of proteins.

Authors:  H Frauenfelder; S G Sligar; P G Wolynes
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

Review 5.  Recent developments of the quantum chemical cluster approach for modeling enzyme reactions.

Authors:  Per E M Siegbahn; Fahmi Himo
Journal:  J Biol Inorg Chem       Date:  2009-05-13       Impact factor: 3.358

6.  Accessing protein conformational ensembles using room-temperature X-ray crystallography.

Authors:  James S Fraser; Henry van den Bedem; Avi J Samelson; P Therese Lang; James M Holton; Nathaniel Echols; Tom Alber
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-14       Impact factor: 11.205

7.  Theoretical and experimental investigations of electrostatic effects on acetylcholinesterase catalysis and inhibition.

Authors:  S Malany; N Baker; M Verweyst; R Medhekar; D M Quinn; B Velan; C Kronman; A Shafferman
Journal:  Chem Biol Interact       Date:  1999-05-14       Impact factor: 5.192

8.  Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman.

Authors:  L P de Jong; G Z Wolring
Journal:  Biochem Pharmacol       Date:  1984-04-01       Impact factor: 5.858

9.  Crystal structures of oxime-bound fenamiphos-acetylcholinesterases: reactivation involving flipping of the His447 ring to form a reactive Glu334-His447-oxime triad.

Authors:  Andreas Hörnberg; Elisabet Artursson; Rikard Wärme; Yuan-Ping Pang; Fredrik Ekström
Journal:  Biochem Pharmacol       Date:  2009-09-02       Impact factor: 5.858

10.  The role of glutamate-199 in the aging of cholinesterase.

Authors:  A Saxena; B P Doctor; D M Maxwell; D E Lenz; Z Radic; P Taylor
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

View more
  12 in total

1.  Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.

Authors:  Oksana Gerlits; Xiaotian Kong; Xiaolin Cheng; Troy Wymore; Donald K Blumenthal; Palmer Taylor; Zoran Radić; Andrey Kovalevsky
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

2.  Development of versatile and potent monoquaternary reactivators of acetylcholinesterase.

Authors:  Lukas Gorecki; Vendula Hepnarova; Jana Zdarova Karasova; Martina Hrabinova; Charlotte Courageux; José Dias; Tomas Kucera; Tereza Kobrlova; Lubica Muckova; Lukas Prchal; David Malinak; Daniel Jun; Kamil Musilek; Franz Worek; Florian Nachon; Ondrej Soukup; Jan Korabecny
Journal:  Arch Toxicol       Date:  2021-01-31       Impact factor: 5.153

3.  Identification of new allosteric sites and modulators of AChE through computational and experimental tools.

Authors:  Carlos Roca; Carlos Requena; Víctor Sebastián-Pérez; Sony Malhotra; Chris Radoux; Concepción Pérez; Ana Martinez; Juan Antonio Páez; Tom L Blundell; Nuria E Campillo
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

4.  The structural and biochemical impacts of monomerizing human acetylcholinesterase.

Authors:  Stephanie M Bester; Kaylin A Adipietro; Vanessa L Funk; James M Myslinski; Nicholas D Keul; Jonah Cheung; Paul T Wilder; Zachary A Wood; David J Weber; Jude J Height; Scott D Pegan
Journal:  Protein Sci       Date:  2019-05-03       Impact factor: 6.725

5.  Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators.

Authors:  David Malinak; Rafael Dolezal; Vendula Hepnarova; Miroslava Hozova; Rudolf Andrys; Petr Bzonek; Veronika Racakova; Jan Korabecny; Lukas Gorecki; Eva Mezeiova; Miroslav Psotka; Daniel Jun; Kamil Kuca; Kamil Musilek
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates.

Authors:  Hyun Myung Lee; Rudolf Andrys; Jakub Jonczyk; Kyuneun Kim; Avinash G Vishakantegowda; David Malinak; Adam Skarka; Monika Schmidt; Michaela Vaskova; Kamil Latka; Marek Bajda; Young-Sik Jung; Barbara Malawska; Kamil Musilek
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase.

Authors:  Jakub Jończyk; Jędrzej Kukułowicz; Kamil Łątka; Barbara Malawska; Young-Sik Jung; Kamil Musilek; Marek Bajda
Journal:  Biomolecules       Date:  2021-01-27

Review 8.  A Comprehensive Review of Cholinesterase Modeling and Simulation.

Authors:  Danna De Boer; Nguyet Nguyen; Jia Mao; Jessica Moore; Eric J Sorin
Journal:  Biomolecules       Date:  2021-04-15

9.  Identification and Study of Biomarkers from Novichok-Inhibited Butyrylcholinesterase in Human Plasma.

Authors:  Woo-Hyeon Jeong; Jin-Young Lee; Kyoung-Chan Lim; Hyun-Suk Kim
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

10.  An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet.

Authors:  Anders Allgardsson; C David Andersson; Christine Akfur; Franz Worek; Anna Linusson; Fredrik Ekström
Journal:  Molecules       Date:  2017-08-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.